Tag Archives: Reckitt Benckiser Pharmaceuticals Demerger

Reckitt Benckiser To End Addiction To Suboxone, Spinoff Pharmaceuticals Unit

Supposedly addicts make great repeat customers, but unfortunately for Reckitt Benckiser (OTC:RBGLY), they (or at least insurers and pharmacies) are quite price sensitive. That seems to be one of the underlying reasons behind the consumer brand giant’s recent announcement of plans to spin off its pharmaceuticals business. The majority of the units’ $1.3b in revenues come from sales of… Read More »